Sustained Efficacy of Natalizumab in the Treatment of Relapsing-Remitting Multiple Sclerosis Independent of Disease Activity and Disability at Baseline : Real-Life Data From a Swiss Cohort

Details

Request a copyRequest a copy
Serval ID
serval:BIB_58874F461065
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Production externe
Title
Sustained Efficacy of Natalizumab in the Treatment of Relapsing-Remitting Multiple Sclerosis Independent of Disease Activity and Disability at Baseline : Real-Life Data From a Swiss Cohort
Journal
Clinical Neuropharmacology
Author(s)
Kallweit Ulf, Jelcic Ilijas, Braun Nathalie, Fischer Heike, Zörner Björn, Schreiner Bettina, Sokolov Arseny A., Martin Roland, Weller Michael, Linnebank Michael
ISSN
0362-5664
Publication state
Published
Issued date
2012
Volume
35
Number
2
Pages
77-80
Language
english
Keywords
Pharmacology (medical), Pharmacology, Clinical Neurology
DOI
10.1097/wnf.0b013e31824644e6
Pubmed
22318192
Web of science
000301866900005
Create date
19/01/2018 14:00
Last modification date
20/08/2019 14:12
Usage data